MarketCapExport financials
Bioceres Crop Solutions Corp. (BIOX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Bioceres Crop Solutions Corp. Financial Ratios 2025-2011 | BIOX
Brief overview of Bioceres Crop Solutions Corp.'s market valuation
Current figures are compared with the company's own five-year history for 2020–2024.
The current valuation set is P/E 54.83x (median 46.18x), EV/EBITDA 18.68x (median 19.25x), P/S 0.31x (median 1.4x). The current ratio basket stands about 77.6% below the five-year comparison base. Earnings and risk trends should explain the discount.
Earnings yield calculated as 1/P/E is about 1.8%, showing current profit per unit of share price.
Capital efficiency is characterized by ROE -19.9%, ROA -7.7%, ROCE -0.5%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
What the ratios show
Bioceres Crop Solutions Corp. trades below its own history, but weak profitability may explain the discount. Low multiples alone do not prove undervaluation.
Annual Financial Ratios Bioceres Crop Solutions Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.8 | 54.8 | 37.5 | -120.0 | -129.2 | 88.2 | -10.5 | -14.3 | - | - | - | - | - | - | - | |
P/S |
0.3 | 0.9 | 1.8 | 1.4 | 2.4 | 1.7 | 1.1 | 1.2 | - | - | - | - | - | - | - |
EPS |
-0.9 | 0.1 | 0.3 | -0.2 | -0.2 | 0.1 | -0.6 | -0.4 | - | -0.2 | - | - | - | - | - |
EV (Enterprise Value) |
541 M | 856 M | 1.2 B | 796 M | 762 M | 490 M | 349 M | 319 M | - | - | - | - | - | - | - |
EBITDA per Share |
-0.04 | 0.73 | 0.87 | 0.94 | 0.98 | 1.08 | 1.05 | 0.56 | - | 0.01 | - | - | - | - | - |
EV/EBITDA |
-241.8 | 18.7 | 22.1 | 20.0 | 19.9 | 7.3 | 10.9 | 16.2 | - | - | - | - | - | - | - |
PEG |
0.06 | -8.06 | 2.7 | - | - | 0.47 | 0.8 | 37.69 | - | - | - | - | - | - | - |
P/B |
0.4 | 1.1 | 2.3 | 3.0 | 5.5 | 4.9 | 2.8 | 4.8 | - | - | - | - | - | - | - |
P/CF |
2.1 | 9.6 | 292.4 | -26.8 | -79.6 | 31.8 | 5.8 | 8.6 | - | - | - | - | - | - | - |
ROE % |
-19.93 | 2.07 | 6.10 | -2.47 | -4.23 | 5.53 | -26.34 | -33.32 | - | -7.39 | - | - | - | - | - |
ROA % |
-7.71 | 0.85 | 2.47 | -0.75 | -0.97 | 1.13 | -6.75 | -5.61 | - | - | - | - | - | - | - |
ROCE % |
-0.53 | 8.76 | 10.43 | 13.49 | 16.94 | 23.45 | 25.46 | 47.42 | - | 0.25 | - | - | - | - | - |
Current Ratio |
1.6 | 1.7 | 1.7 | 1.4 | 1.3 | 1.3 | 1.3 | 1.2 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Bioceres Crop Solutions Corp.
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.8836 | -0.1155 | -0.7565 | -0.0208 | 0.0023 | -0.1013 | -0.007999999999999993 | 0.1473 | 0.0017 | -0.0731 | -0.028200000000000003 | 0.454 | -0.1323 | - | - | 0.0834 | - | 0.0834 | - | 0.0171 | - | 0.0171 | - | - | - | 0.3133 | - | 0.3133 | - | 0.19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
0.12 | 0.11 | -30.4 | 0.01 | 0.23 | 0.04 | 4.27 K | 0.21 | 0.27 | 0.08 | 35.4 | 0.48 | 0.04 | - | - | 0.43 | - | 0.42 | - | 0.3 | - | 0.3 | - | - | - | 0.54 | - | 0.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-24.74 | -18.62 | -17.83 | -0.63 | 2.64 | 1.09 | 2.07 | 1.53 | 6.94 | 3.82 | 9.42 | 16.18 | 10.27 | 13.02 | 13.02 | 15.98 | 11.18 | 31.56 | 25.64 | 46.36 | 44.05 | 64.41 | 61.45 | 61.45 | 61.45 | 20.37 | - | 20.71 | - | 20.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-8.78 | -7.18 | -6.92 | -0.27 | 1.09 | 0.45 | 0.87 | 0.65 | 2.73 | 1.61 | 3.08 | 4.77 | 2.04 | 3.01 | 3.01 | 3.61 | 2.48 | 7.69 | 6.34 | 11.18 | 10.66 | 0.60 | - | - | - | 5.22 | - | 4.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
1.94 | 1.32 | 0.11 | 5.28 | 7.71 | 8.43 | 9.03 | 8.00 | 10.87 | 7.92 | 13.00 | 19.83 | 20.72 | 20.31 | 20.31 | 27.22 | 21.11 | 36.63 | 28.82 | 44.86 | 38.48 | 73.14 | 66.23 | 66.23 | 66.23 | 15.53 | - | 16.04 | - | 34.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.6 | 1.6 | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.5 | 1.4 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | 1.3 | - | - | - | 1.2 | - | - | - | 1.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Bioceres Crop Solutions Corp., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
CF Industries Holdings
CF
|
$ 122.16 | 2.41 % | $ 19.8 B |  USA |
 |
The Mosaic Company
MOS
|
$ 22.88 | 0.46 % | $ 7.26 B | USA |
 |
Corteva
CTVA
|
$ 12.17 | 0.5 % | $ 8.28 B | USA |
 |
Nutrien Ltd.
NTR
|
$ 72.18 | -0.15 % | $ 35.1 B |  Canada |
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Origin Agritech Limited
SEED
|
$ 0.68 | 3.88 % | $ 5.09 M |  China |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
American Vanguard Corporation
AVD
|
$ 0.83 | 1.21 % | $ 23.6 M | USA |
 |
ICL Group Ltd
ICL
|
$ 4.68 | -1.07 % | $ 6.04 B |  Israel |
 |
Arcadia Biosciences
RKDA
|
$ 0.16 | -5.61 % | $ 219 K | USA |
 |
Intrepid Potash
IPI
|
$ 33.42 | 0.48 % | $ 435 M | USA |
 |
FMC Corporation
FMC
|
$ 5.65 | 4.34 % | $ 707 M | USA |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 65.1 | -1.87 % | $ 3.75 B | USA |
 |
CVR Partners, LP
UAN
|
$ 111.9 | 0.48 % | $ 1.18 B | USA |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M | China |